Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT02889081Completed

Maternal Key Nutritional Factors and Offspring's Atopic Dermatitis (MKNFOAD)

Role: collaborator

NCT06316609Active Not Recruiting

Prenatal Exposure to Emerging Contaminants and Children's Atopic Dermatitis

Role: collaborator

NCT01669057Completed

Study on Clinical Prognosis, Risk Factors and Genetic Basis of Congenital Heart Disease

Role: collaborator

All 3 trials loaded